ClinicalTrials.govpublic full text
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
hr+/her2-negative breast cancer, pi3k-alpha, breast cancer, metastatic breast cancer, pik3ca, hormone receptor positive breast cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 802779
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.